Cytokine release syndrome after allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide: current understanding and management.

Front Immunol · 2026 · PMC13180612 · PMID 42158862

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

On the other hand, tocilizumab has demonstrated efficacy in the treatment of acute GVHD ( 40 ), and, in a phase III trial, showed a nonsignificant trend toward lower incidence of grade II-IV aGVHD In the HLA-matched unrelated donor transplant setting ( 41 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.